Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director Declaration

21 Nov 2018 12:00

RNS Number : 9084H
Genus PLC
21 November 2018
 

21 November 2018

Genus plc

Director Declaration

Genus plc (LSE: GNS) today announces that Lykele van der Broek, Non-Executive Director, has been appointed as a Non-Executive Director and Chairman of the Supervisory Board of Aspen Oss B.V., a manufacturer of active pharmaceutical ingredients in the human healthcare sector, which is a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd listed on the Johannesburg Stock Exchange, with effect from 21 November 2018.

This announcement is being made pursuant to 9.6.14 of the Listing Rules.

 

For further information please contact:

Genus:

Dan Hartley, Group General Counsel & Company Secretary Tel: +44 (0)1256 347100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNBBLFLVFFEFBX
Date   Source Headline
31st Mar 20084:00 pmRNSTotal Voting Rights
31st Mar 20084:00 pmRNSBlocklisting Interim Review
20th Mar 20082:08 pmRNSHolding(s) in Company
17th Mar 20083:21 pmRNSHolding(s) in Company
13th Mar 20082:00 pmRNSHolding(s) in Company
29th Feb 20082:00 pmRNSTotal Voting Rights
27th Feb 20085:02 pmRNSDirector/PDMR Shareholding
26th Feb 20084:54 pmRNSDirector/PDMR Shareholding
26th Feb 20087:00 amRNSInterim Results
22nd Feb 200811:56 amRNSHolding(s) in Company
31st Jan 20082:00 pmRNSBlocklisting Interim Review
17th Jan 20087:00 amRNSBoard Changes
15th Jan 20088:00 amRNS1st dealings on AIM
15th Jan 20088:00 amRNSDisposal
14th Jan 20085:40 pmRNSHolding(s) in Company
9th Jan 200811:00 amRNSAppointment of New Adviser
2nd Jan 20083:15 pmRNSTotal Voting Rights
30th Nov 20078:00 amRNSTotal Voting Rights
27th Nov 20077:01 amRNSDisposal
15th Nov 20073:39 pmRNSResult of AGM
15th Nov 20077:01 amRNSAGM Statement
12th Nov 20078:24 amRNSAdmission to Official List
12th Nov 20078:00 amRNSCancellation - 12/11/2007
7th Nov 20077:57 amRNSPublication of Prospectus
6th Nov 200712:51 pmRNSHolding(s) in Company
6th Nov 20077:00 amRNSDisposal
1st Nov 20075:53 pmRNSDirector/PDMR Shareholding
1st Nov 20077:02 amRNSPlacing
31st Oct 20079:20 amRNSTotal Voting Rights
18th Oct 20072:30 pmRNSDirector/PDMR Shareholding
12th Oct 20077:01 amRNSMove to the Official List
4th Oct 20077:01 amRNSDisposal of SyAqua Mexico
28th Sep 20077:01 amRNSTotal Voting Rights
24th Sep 20072:11 pmRNSDirector/PDMR Shareholding
18th Sep 20077:02 amRNSPreliminary Results
12th Sep 20072:55 pmRNSStatement re: Foot & Mouth
5th Sep 20075:16 pmRNSBlocklisting Interim Review
17th Aug 20072:55 pmRNSChange of Adviser
10th Aug 20074:28 pmRNSAIM Rule 26
6th Aug 20077:01 amRNSStatement Re: Foot & Mouth
25th Jul 20072:00 pmRNSBlocklisting Interim Review
18th Jul 20077:01 amRNSPre-Close Trading Update
7th Jun 20076:35 pmRNSHolding(s) in Company
7th Jun 20076:33 pmRNSHolding(s) in Company
19th Apr 20075:13 pmRNSDirector/PDMR Shareholding
12th Apr 200710:58 amRNSHolding(s) in Company
29th Mar 20077:00 amRNSHolding(s) in Company
13th Mar 20077:02 amRNSBoard Change
13th Mar 20077:01 amRNSInterim Results
5th Mar 20074:43 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.